Unibest
← Back to patent-cliff list

CAS 3724-43-4

N-(chloromethylene)-N-methylmethanaminium chloride

Codes: VILD-004, SUNT-007

Application context (from source-drug indications)

Type 2 diabetesVildagliptinSchizophreniaVildagliptinDyslipidaemiaVildagliptinInsulin resistanceVildagliptinType 1 diabetesVildagliptinDiabetesVildagliptinPancreatic neuroendocrine tumourSunitinib MalateRenal cell carcinomaSunitinib MalateGastrointestinal stromal tumourSunitinib MalateOsteosarcomaSunitinib MalateSarcomaSunitinib MalateLymphomaSunitinib Malate

Source drugs (routes using this intermediate)

DrugTierExpiry
VildagliptinTier B — Position early-
Sunitinib MalateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works5-Fluoro-2-oxindole
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.